Kawamoto, Y., Nakajima, H., Komatsu, Y., Kubota, H., Tsukamoto, K., Takahashi, K., Kobayashi, K., Kotani, H., Hara, F., Kato, T., Nonomura, N., Ikeno, T., Wakabayashi, M., Sato, A., Naito, Y. (2025). A phase 1 study of PARP inhibitor (niraparib) plus HSP90 inhibitor (pimitespib) in solid tumors: Dose-expansion results from the NiraPim (EPOC2102) study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3079